BTNL9 proteins, nucleic acids, and antibodies and uses thereof

Details for Australian Patent Application No. 2011237365 (hide)

Owner Amgen Inc.

Inventors Arnett, Heather A.; Escobar, Sabine S.; Swanson, Ryan M.; Viney, Joanne L.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2011237365

PCT Pub. Number WO2011/127418

Priority 61/322,800 09.04.10 US

Filing date 8 April 2011

Wipo publication date 13 October 2011

International Classifications

C07K 14/705 Peptides having more than 20 amino acids

A61K 38/17 Medicinal preparations containing peptides - from animals

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

C12N 5/00 Undifferentiated human, animal or plant cells, e.g. cell lines

C12N 15/00 Mutation or genetic engineering

Event Publications

18 October 2012 PCT application entered the National Phase

  PCT publication WO2011/127418 Priority application(s): WO2011/127418

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011237368-Exoskeleton load handling system and method of use

2011237361-Electromagnetic forming of metallic glasses using a capacitive discharge and magnetic field